International Clinical Trial: Elowen-2 : A Study of Enpatoran in Cutaneous Manifestations of Lupus With or Without Systemic Disease

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607871198123) titled 'Elowen-2 : A Study of Enpatoran in Cutaneous Manifestations of Lupus With or Without Systemic Disease' on July 31.

Study Type: Interventional

Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Central randomisation by phone/fax

Primary Sponsor: Merck Healthcare KGaA

Condition: Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease

Interventi...